The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1148493615 11484936 15 F 2015 20160801 20150909 20160808 EXP CA-SA-2015SA116925 AVENTIS 38.00 YR A F Y 0.00000 20160808 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1148493615 11484936 1 PS LEMTRADA ALEMTUZUMAB 1 Intravenous (not otherwise specified) F3005H46 103948 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION QD
1148493615 11484936 2 SS SOLU-MEDROL METHYLPREDNISOLONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) U UNKNOWN 0 1 G
1148493615 11484936 3 C CHROME 2 Oral 0
1148493615 11484936 4 C FAMPYRA DALFAMPRIDINE 1 Oral 0
1148493615 11484936 5 C VITAMIN D CHOLECALCIFEROL 1 Oral 0
1148493615 11484936 6 C ACYCLOVIR. ACYCLOVIR 1 Oral 0 200 MG
1148493615 11484936 7 C RANITIDINE. RANITIDINE 1 Oral 0 150 MG
1148493615 11484936 8 C REACTINE CETIRIZINE HYDROCHLORIDE 1 Oral 0 5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1148493615 11484936 1 Relapsing-remitting multiple sclerosis
1148493615 11484936 2 Premedication
1148493615 11484936 4 Multiple sclerosis
1148493615 11484936 5 Multiple sclerosis
1148493615 11484936 6 Premedication
1148493615 11484936 7 Premedication
1148493615 11484936 8 Premedication

Outcome of event

Event ID CASEID OUTC COD
1148493615 11484936 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1148493615 11484936 Abdominal discomfort
1148493615 11484936 Abdominal pain
1148493615 11484936 Back pain
1148493615 11484936 Bacterial test
1148493615 11484936 Blood urine present
1148493615 11484936 Chills
1148493615 11484936 Dyspepsia
1148493615 11484936 Eructation
1148493615 11484936 Erythema
1148493615 11484936 Headache
1148493615 11484936 Hyperthermia
1148493615 11484936 Immunodeficiency
1148493615 11484936 Lymphocyte count decreased
1148493615 11484936 Lymphocyte percentage decreased
1148493615 11484936 Nasopharyngitis
1148493615 11484936 Nausea
1148493615 11484936 Neck pain
1148493615 11484936 Neutrophil percentage increased
1148493615 11484936 Nitrite urine present
1148493615 11484936 Poor quality sleep
1148493615 11484936 Pruritus
1148493615 11484936 Red blood cells urine positive
1148493615 11484936 Specific gravity urine decreased
1148493615 11484936 Urinary sediment present
1148493615 11484936 Urinary tract infection
1148493615 11484936 Urine analysis abnormal
1148493615 11484936 Vaginal discharge
1148493615 11484936 Vomiting
1148493615 11484936 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1148493615 11484936 1 20150803 20150807 0
1148493615 11484936 2 20150803 20150807 0
1148493615 11484936 6 20150803 20150907 0
1148493615 11484936 7 20150802 20150807 0
1148493615 11484936 8 20150802 20150807 0